Modelling the prevalence and cost of back pain with neuropathic components in the general population

European Journal of Pain

Volumn 13, Issue 10, 2009, Pages 1030-1035

  Schmidt, Carsten O ^a   Schweikert, Bernd ^b,c   Wenig, Christina M ^b,c   Schmidt, Uwe ^d   Gockel, Ulrich ^e   Freynhagen, Rainer ^f   Tölle, Thomas R ^g   Baron, Ralf ^h   Kohlmann, Thomas ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d StatConsult GmbH   (Germany)

^e PFIZER INC   (United States)

^f UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY OF KIEL   (Germany)

Author keywords

Cost of illness; General population; Low back pain; Neuropathic pain

Indexed keywords

ADULT; ARTICLE; BACKACHE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; NEUROPATHIC PAIN; PAIN ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

ADULT; BACK PAIN; DATABASES, FACTUAL; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; MODELS, STATISTICAL; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 65649129941     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.12.003     Document Type: Article

References (35)

1. Bennett M. The LANSS pain scale: the leeds assessment of neuropathic symptoms and signs. Pain 92 (2001) 147-157
2. Bennett M.I., Smith B.H., Torrance N., and Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 6 (2005) 149-158
3. Bennett M.I., Attal N., Backonja M.M., Baron R., Bouhassira D., Freynhagen R., et al. Using screening tools to identify neuropathic pain. Pain 127 3 (2007) 199-203
4. Berger A., Dukes E.M., and Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 5 (2004) 143-149
5. Bouhassira D., Attal N., Alchaar H., Boureau F., Brochet B., Bruxelle J., et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114 (2005) 29-36
6. Bouhassira D., Attal N., Fermanian J., Alchaar H., Gautron M., Masquelier E., et al. Development and validation of the neuropathic pain symptom inventory. Pain 108 (2004) 248-257
7. Bouhassira D., Lantéri-Minet M., Attal N., Laurent B., and Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136 (2008) 380-387
8. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J., et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60 (2003) 1524-1534
9. Evans C., and Crawford B. Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity. Pharmacoeconomics 15 (1999) 241-256
10. Freynhagen R., Baron R., Gockel U., and Tölle T.R. Pain DETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22 (2006) 1911-1920
11. Galer B.S., and Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology 48 (1997) 332-338
12. Gilron I., Watson C.P., Cahill C.M., and Moulin D.E. Neuropathic pain: a practical guide for the clinician. Can Med Assoc J 175 (2006) 265-275
13. Jensen T.S., Gottrup H., Sindrup S.H., and Bach F.W. The clinical picture of neuropathic pain. Eur J Pharmacol 429 (2001) 1-11
14. Junker U., Freynhagen R., Langler K., Gockel U., Schmidt U., Tolle T.R., et al. Paper versus electronic rating scales for pain assessment: a prospective, randomised, cross-over validation study with 200 chronic pain patients. Curr Med Res Opin 24 6 (2008) 1797-1806
15. Koes B.W., van Tulder M.W., and Thomas S. Diagnosis and treatment of low back pain. Brit Med J 332 (2006) 1430-1434
16. Kohlmann T., and Raspe H. Der funktionsfragebogen hannover zur alltagsnahen diagnostik der funktionsbeeinträchtigung durch rückenschmerzen (FFbH-R). Rehabilitation 35 (1996) 1-8
17. Krause S.J., and Backonja M. Development of a neuropathic pain questionnaire. Clin J Pain 19 (2003) 306-314
18. Krauth C., Hessel F., Hansmeier T., Wasem J., Seitz R., and Schweikert B. [Empirical standard costs for health economic evaluation in Germany - a proposal by the working group methods in health economic evaluation] article in German. Gesundheitswesen 67 (2005) 736-746
19. Lachaine J., Gordon A., Choiniere M., Collet J.P., Dion D., and Tarride J.E. Painful neuropathic disorders: an analysis of the regie de l'assurance maladie du quebec database. Pain Res Manage 12 (2007) 31-37
20. Lord J., and Asante M. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis. Health Econom 8 4 (1999) 323-333
21. Maniadakis N., and Gray A. The economic burden of back pain in the UK. Pain 84 (2000) 95-103
22. McDermott A.M., Tölle T.R., Rowbotham D.J., Schaefer C.P., and Dukes E.M. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 10 (2006) 127-135
23. Raja S.N., and Haythornthwaite J.A. Combination therapy for neuropathic pain - which drugs, which combination, which patients?. New Engl J Med 352 (2005) 1373-1375
24. Raspe H. Back pain. In: Silman A.J., and Hochberg M.C. (Eds). Epidemiology of the rheumatic diseases (2001), Oxford University Press, Oxford 309-338
25. Rodriguez M.J., and Garcia A.J. A registry of the aetiology and costs of neuropathic pain in pain clinics: results of the registry of aetiologies and costs (REC) in neuropathic pain disorders study. Clin Drug Invest 27 (2007) 771-782
26. Rote Liste Service G.m.b.H. Rote liste: arzneimittelverzeichnis für deutschland (Tarif list for drugs in Germany) (2006), Editio Cantor Verlag, Aulendorf
27. Royston P. Multiple imputation of missing values: update. STATA J 5 (2005) 1-14
28. Sadosky A., McDermott A.M., Brandenburg N.A., and Strauss M. A review of the epidemiology of painful diabetic peripheral neuropathy, posttherapeutic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 8 (2008) 45-56
29. Schmidt C.O., Raspe H., Pfingsten M., Hasenbring M., Basler H.D., Eich W., et al. Back pain in the German adult population: prevalence, severity, and sociodemographic correlates in a multiregional survey. Spine 32 (2007) 2005-2011
30. Sieper J., Rudwaleit M., Khan M.A., and Braun J. Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol 20 (2006) 401-417
31. Stewart W.F., Ricci J.A., Chee E., Morganstein D., and Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 290 (2003) 2443-2454
32. Torrance N., Smith B.H., Bennett M.I., and Lee A.J. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7 (2006) 281-289
33. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70 18 (2008) 1630-1635
34. Wenig C.M., Schmidt C.O., Kohlmann T., and Schweikert B. Costs of back pain in Germany. Eur J Pain 13 (2009) 280-286
35. Woolf A.D., and Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Org 81 (2003) 646-656